Interdisciplinary Research Training in Reproduction for Indian Fellows
为印度研究员提供跨学科生殖研究培训
基本信息
- 批准号:7595215
- 负责人:
- 金额:$ 19.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-09-30 至 2011-03-31
- 项目状态:已结题
- 来源:
- 关键词:Acrosome ReactionAntigensAppointmentArtsAutoimmunityBinding SitesBioethicsBiometryCircadian RhythmsClinicalClinical InvestigatorCollaborationsCommunicationContraceptive AgentsContraceptive VaccinesContraceptive methodsDevelopmentDiagnosticDoctor of PhilosophyEnvironmentEpididymisFacultyFosteringGenetic TranscriptionIndiaInfertilityInstitutionInstructionInterdisciplinary StudyInternational CooperationInternistIon ChannelKnowledgeLigand BindingLinkMale Contraceptive AgentsMembraneMentorsMolecularMolecular AnalysisMolecular and Cellular BiologyNeurosecretory SystemsNuclearOogenesisOrganic SynthesisPathway interactionsPharmacologyPhysiciansPhysiologyPositioning AttributePregnancyProteinsRecombinantsReproductionReproductive ProcessRequest for ApplicationsResearchResearch Project GrantsResearch TrainingScienceScientistSignal TransductionSperm CapacitationSperm MaturationSpermatocidal AgentsSpermatogenesisTechnologyTestingTestisTrainingTraining ProgramsUrologistVisitWritingX-Ray Crystallographybasebiomedical scientistcandidate identificationcareercollegecontraceptive targetdesigndrug discoveryeggexperienceimprovedinhibitor/antagonistmathematical modelmedical schoolsmeetingsnovelprofessorprogramsreceptorreproductiveskillssmall moleculesperm cellstructural genomicssymposiumtooltranscription factor
项目摘要
This competing continuation application requests support to train three PhD scientists or post-resident
physicians [MD or PhD/MD], holding positions at two partner institutions in India, for investigative careers in
reproductive research. Emphasis will be placed on training in cell and molecular biology of reproduction with
translational components aimed at infertility and the discovery of new leads for contraceptives. The global
need for new options in contraception is highlighted by the fact that one in every two pregnancies is
unwanted. Deployment of known contraceptives as well as advancement of new contraceptive options is a
highest priority. This training program develops biomedical scientists who can meet the challenges of
contraceptive discovery by equipping them with the tools to investigate the fundamental mechanisms
governing reproductive processes, to recognize the opportunities afforded by such basic knowledge for
identification of candidate contraceptive pathways and target molecules, and to test novel contraceptive
strategies. Research and didactic experiences are tailored to accommodate trainees from diverse
professional and academic backgrounds. Supplemental instruction is offered including courses in
biostatistics, English for scientific purposes to improve writing and communication skills, recombinant DMA
technology, structural genomics, pharmacology, bioethics, and drug discovery, design, synthesis, and
selection. Interdisciplinary research training is achieved through interactions with preceptors who hold
appointments in basic and clinical departments, through programs that evaluate leads and establish proof of
principle of contraceptive action, and through collaboration with industrial advisors. All mentors hold faculty
appointments in the School of Medicine or the College of Arts and Sciences and direct at least one active
research grant. The institutional environment fosters interaction and exchange through a rich mix of
seminars, visiting professors, conferences, and specialized research cores. The broad basic themes of
faculty research programs include: the molecular analysis of sperm-egg fusion, signal transduction
mechanisms between membrane receptors, sperm capacitation and the acrosome reaction, protein
transcription, nuclear transcription factors, molecular physiology of ion channels, neuroendocrine control of
mechanisms in reproduction, molecular control of spermatogenesis and oogenesis, autoimmunity to sperm
antigens; sperm maturation in the epididymis, and circadian rhythms. Translational aims are fostered by
faculty expertise in X-ray crystallography of reproductive proteins, mathematical modeling of ligand binding
sites and organic synthesis of new small molecule inhibitors and the testing of their contraceptive action.
Applied themes of this research include the development of male contraceptives targeted to transcription
factors acting in the testis and epididymis, spermicides, infertility diagnostics, and contraceptive vaccines
based on sperm and egg antigens. Continued training of basic scientists as well as internists, urologists,
and obstetricians in cellular and molecular approaches to reproductive processes is consistent with the
tradition and commitment to foster a close link between basic and clinical investigators at US institutions
and their counterparts in India and to facilitate international cooperation and understanding.
这一竞争性的继续申请要求支持培训三名博士科学家或后居民
医生[医学博士或博士/医学博士],在印度的两个合作机构担任职务,从事研究工作,
生殖研究重点将放在细胞和生殖分子生物学的培训上,
转译成分,旨在不孕症和发现新的线索避孕药。全球
每两次怀孕中就有一次是在
不想要的。部署已知的避孕药具以及推进新的避孕选择是一个
最高优先级该培训计划培养生物医学科学家,他们能够应对以下挑战:
避孕发现,为他们提供研究基本机制的工具
认识到这些基本知识所提供的机会,
鉴定候选避孕途径和靶分子,并测试新型避孕药
战略布局研究和教学经验是量身定制,以适应学员从不同的
专业和学术背景。提供补充指导,包括以下课程:
生物统计学,科学英语,以提高写作和沟通技巧,重组DMA
技术,结构基因组学,药理学,生物伦理学和药物发现,设计,合成,
选择.跨学科的研究培训是通过与导师谁持有互动
在基础和临床部门的任命,通过评估线索和建立证据的计划,
避孕行动的原则,并通过与工业顾问合作。所有导师都有教职员工
任命在医学院或艺术和科学学院,并直接至少一个积极的
研究补助金制度环境通过丰富的组合促进互动和交流
研讨会、客座教授、会议和专门研究核心。广泛的基本主题
教师研究计画包括:精卵融合的分子分析,讯号传导
膜受体、精子获能和顶体反应、蛋白质
转录,核转录因子,离子通道分子生理学,神经内分泌调控,
生殖机制,精子发生和卵子发生的分子控制,对精子的自身免疫
抗原;精子在附睾中的成熟和昼夜节律。翻译目标的培养是
在生殖蛋白的X射线晶体学,配体结合的数学建模教师的专业知识
新的小分子抑制剂的有机合成及其避孕作用的测试。
这项研究的应用主题包括针对转录的男性避孕药的开发
作用于睾丸和附睾的因子、杀精剂、不孕症诊断和避孕疫苗
基于精子和卵子的抗原继续培训基础科学家以及内科医生、泌尿科医生,
和产科医生在生殖过程的细胞和分子方法是一致的,
传统和承诺,以促进美国机构的基础和临床研究者之间的密切联系
并促进国际合作和理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN C HERR其他文献
JOHN C HERR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN C HERR', 18)}}的其他基金
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
结构靶向睾丸特异性激酶 (TSSK) 1
- 批准号:
7770849 - 财政年份:2009
- 资助金额:
$ 19.18万 - 项目类别:
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
结构靶向睾丸特异性激酶 (TSSK) 1
- 批准号:
8433483 - 财政年份:2009
- 资助金额:
$ 19.18万 - 项目类别:
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
结构靶向睾丸特异性激酶 (TSSK) 1
- 批准号:
8235939 - 财政年份:2009
- 资助金额:
$ 19.18万 - 项目类别:
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
结构靶向睾丸特异性激酶 (TSSK) 1
- 批准号:
7842389 - 财政年份:2009
- 资助金额:
$ 19.18万 - 项目类别:
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
结构靶向睾丸特异性激酶 (TSSK) 1
- 批准号:
8049752 - 财政年份:2009
- 资助金额:
$ 19.18万 - 项目类别:
Structural Targeting Testis Specific Kinases (TSSK) 1 & 2 for Male Contraception
结构靶向睾丸特异性激酶 (TSSK) 1
- 批准号:
7626131 - 财政年份:2009
- 资助金额:
$ 19.18万 - 项目类别:
IMMUNODOMINANT OVARIAN ANTIGENS INVOLVED IN PREMATURE OVARIAN FAILURE
与卵巢早衰相关的免疫显性卵巢抗原
- 批准号:
7231552 - 财政年份:2007
- 资助金额:
$ 19.18万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 19.18万 - 项目类别:
Research Grant
A novel vaccine approach combining mosquito salivary antigens and viral antigens to protect against Zika, chikungunya and other arboviral infections.
一种结合蚊子唾液抗原和病毒抗原的新型疫苗方法,可预防寨卡病毒、基孔肯雅热和其他虫媒病毒感染。
- 批准号:
10083718 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Small Business Research Initiative
Uncovering tumor specific antigens and vulnerabilities in ETP-acute lymphoblastic leukemia
揭示 ETP-急性淋巴细胞白血病的肿瘤特异性抗原和脆弱性
- 批准号:
480030 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Operating Grants
Regulation of B cell responses to vaccines by long-term retention of antigens in germinal centres
通过在生发中心长期保留抗原来调节 B 细胞对疫苗的反应
- 批准号:
MR/X009254/1 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Research Grant
Adaptive Discrimination of Risk of Antigens in Immune Memory Dynamics
免疫记忆动态中抗原风险的适应性辨别
- 批准号:
22KJ1758 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Grant-in-Aid for JSPS Fellows
22-ICRAD Call 2 - Improving the diagnosis of tuberculosis in domestic ruminants through the use of new antigens and test platforms
22-ICRAD 呼吁 2 - 通过使用新抗原和测试平台改善家养反刍动物结核病的诊断
- 批准号:
BB/Y000927/1 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Research Grant
Protective immunity elicited by distinct polysaccharide antigens of classical and hypervirulent Klebsiella
经典和高毒力克雷伯氏菌的不同多糖抗原引发的保护性免疫
- 批准号:
10795212 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Integrative proteome analysis to harness humoral immune response against tumor antigens
综合蛋白质组分析利用针对肿瘤抗原的体液免疫反应
- 批准号:
23K18249 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Targeting T3SA proteins as protective antigens against Yersinia
将 T3SA 蛋白作为针对耶尔森氏菌的保护性抗原
- 批准号:
10645989 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别:
Functionally distinct human CD4 T cell responses to novel evolutionarily selected M. tuberculosis antigens
功能独特的人类 CD4 T 细胞对新型进化选择的结核分枝杆菌抗原的反应
- 批准号:
10735075 - 财政年份:2023
- 资助金额:
$ 19.18万 - 项目类别: